US$ 21.32
newest glp 1 agonist A Comprehensive Review of the Role of GLP-1 Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure GLP-1 Receptor Agonists in Solid
Description
In this trial, liragutide treated patients not only did not benefit from the therapy, but also had a higher risk of developing arrhythmia and acute coronary syndrome compared to placebo (63)

Rise of Dual and Triple Agonists: Beyond GLP-1, newer drugs target GIP and glucagon receptors for enhanced efficacy (e.g., Tirzepatide, Retatrutide)

10.1186/s12937-024-01048-7 88 WyshamC.BlevinsT.ArakakiR.ColonG.GarciaP.AtissoC.et al (2014)

GLP1-RA and Weight Loss Boom in India

These findings are significant to people with Alzheimers and Parkinsons
